Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.33 Average Target Price from Analysts
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month […]
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month […]
